2.73
price down icon1.26%   -0.04
after-market アフターアワーズ: 2.73
loading
前日終値:
$2.77
開ける:
$2.77
24時間の取引高:
138.82K
Relative Volume:
0.32
時価総額:
$215.99M
収益:
-
当期純損益:
$-29.07M
株価収益率:
-8.8065
EPS:
-0.31
ネットキャッシュフロー:
$-31.85M
1週間 パフォーマンス:
-4.37%
1か月 パフォーマンス:
-18.36%
6か月 パフォーマンス:
+0.18%
1年 パフォーマンス:
+112.02%
1日の値動き範囲:
Value
$2.73
$2.83
1週間の範囲:
Value
$2.67
$3.07
52週間の値動き範囲:
Value
$0.97
$4.00

Trevi Therapeutics Inc Stock (TRVI) Company Profile

Name
名前
Trevi Therapeutics Inc
Name
セクター
Healthcare (1196)
Name
電話
203-304-2499
Name
住所
195 CHURCH STREET, NEW HAVEN, CT
Name
職員
27
Name
Twitter
@TreviThera
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
TRVI's Discussions on Twitter

TRVI を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
TRVI 2.73 215.99M 0 -29.07M -31.85M -0.31
VRTX 450.37 115.10B 10.63B -479.80M -1.35B 13.33
REGN 744.50 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 596.74 35.07B 1.86B -40.29M -1.28B -4.16
ALNY 246.80 32.20B 2.09B -332.26M 16.06M -4.14
BNTX 108.23 25.09B 3.30B -501.07M 1.03B 11.54

Trevi Therapeutics Inc Stock (TRVI) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-04-12 開始されました B. Riley Securities Buy
2022-11-22 開始されました SVB Leerink Outperform
2019-06-03 開始されました BMO Capital Markets Outperform
2019-06-03 開始されました Needham Buy
2019-06-03 開始されました SVB Leerink Outperform
2019-06-03 開始されました Stifel Buy
すべてを表示

Trevi Therapeutics Inc (TRVI) 最新ニュース

pulisher
07:30 AM

Trevi Therapeutics to Present Haduvio Development at Piper Sandler Healthcare Conference | TRVI Stock News - StockTitan

07:30 AM
pulisher
Nov 16, 2024

Trevi Therapeutics to Participate in Upcoming April Events - GuruFocus.com

Nov 16, 2024
pulisher
Nov 16, 2024

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Receives $7.43 Consensus Target Price from Brokerages - Defense World

Nov 16, 2024
pulisher
Nov 14, 2024

Trevi Therapeutics to Present at the Emerging Growth Conference on February 22, 2023 - Quantisnow

Nov 14, 2024
pulisher
Nov 13, 2024

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Receives $7.43 Average PT from Brokerages - MarketBeat

Nov 13, 2024
pulisher
Nov 12, 2024

How Do Things Look For Trevi Therapeutics Inc (NASDAQ: TRVI) In The Short-Term? - Stocks Register

Nov 12, 2024
pulisher
Nov 12, 2024

Trevi Therapeutics Announces Proposed Public Offering - Quantisnow

Nov 12, 2024
pulisher
Nov 12, 2024

Trevi Therapeutics to Participate in Upcoming September Events - Quantisnow

Nov 12, 2024
pulisher
Nov 12, 2024

Trevi Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference - Quantisnow

Nov 12, 2024
pulisher
Nov 12, 2024

Trevi Therapeutics Provides Business Update Ahead of Upcoming Conferences - Quantisnow

Nov 12, 2024
pulisher
Nov 11, 2024

FY2024 Earnings Forecast for TRVI Issued By Leerink Partnrs - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Leerink Partnrs Has Negative Outlook of TRVI FY2024 Earnings - Defense World

Nov 11, 2024
pulisher
Nov 08, 2024

Earnings call: Trevi Therapeutics reports Q3 2024 financials, clinical updates - Investing.com

Nov 08, 2024
pulisher
Nov 08, 2024

Trevi Therapeutics' (TRVI) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 08, 2024
pulisher
Nov 08, 2024

Earnings call: Trevi Therapeutics reports Q3 2024 financials, clinical updates By Investing.com - Investing.com UK

Nov 08, 2024
pulisher
Nov 07, 2024

Trevi Therapeutics Inc (TRVI) Q3 2024 Earnings Call Highlights: - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Trevi Therapeutics Inc (TRVI) Q3 2024 Earnings Call Highlights: Navigating Increased Losses and ... - Yahoo Finance

Nov 07, 2024
pulisher
Nov 07, 2024

Trevi Therapeutics Reports Q3 2024 Progress and Financials - TipRanks

Nov 07, 2024
pulisher
Nov 06, 2024

Trevi Therapeutics Advances Clinical Trials Despite Widening Q3 Losses; Cash Runway Extended | TRVI Stock News - StockTitan

Nov 06, 2024
pulisher
Nov 06, 2024

Rosalind Advisors Inc. Sells 641,577 Shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI) - MarketBeat

Nov 06, 2024
pulisher
Nov 04, 2024

Trevi Therapeutics to Report Third Quarter 2024 Financial Result - GuruFocus.com

Nov 04, 2024
pulisher
Oct 31, 2024

Trevi Therapeutics (TRVI) Set to Announce Earnings on Wednesday - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

Trevi Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on November 6, 2024 - StreetInsider.com

Oct 30, 2024
pulisher
Oct 30, 2024

Trevi Therapeutics Adds Clinical Development Expertise in Chroni - GuruFocus.com

Oct 30, 2024
pulisher
Oct 23, 2024

Rosalind Advisors, Inc. Reduces Stake in Trevi Therapeutics Inc. - Yahoo Finance UK

Oct 23, 2024
pulisher
Oct 22, 2024

Trevi Therapeutics shares retain buy rating on Haduvio prospects By Investing.com - Investing.com UK

Oct 22, 2024
pulisher
Oct 22, 2024

Trevi Therapeutics (NASDAQ:TRVI) Given "Buy" Rating at HC Wainwright - MarketBeat

Oct 22, 2024
pulisher
Oct 21, 2024

Trevi Therapeutics completes enrollment for Phase 2a trial - Investing.com

Oct 21, 2024
pulisher
Oct 21, 2024

Trevi Therapeutics completes enrollment for Phase 2a trial By Investing.com - Investing.com Australia

Oct 21, 2024
pulisher
Oct 21, 2024

Trevi Therapeutics, Inc. Completes Enrollment in the Phase 2A RIVER Trial of Haduvio - Marketscreener.com

Oct 21, 2024
pulisher
Oct 21, 2024

Trevi Therapeutics Completes Enrollment for Phase 2a RIVER Trial in Refractory Chronic Cough - Citizentribune

Oct 21, 2024
pulisher
Oct 19, 2024

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat

Oct 19, 2024
pulisher
Oct 18, 2024

TSX Global Gold Index (TTGD) QuotePress Release - The Globe and Mail

Oct 18, 2024
pulisher
Oct 15, 2024

Trevi Therapeutics to Participate in Upcoming Commercial and Investor Conferences - Citizentribune

Oct 15, 2024
pulisher
Oct 09, 2024

Trevi Therapeutics Inc (TRVI) Q2 2024 Earnings Call Highlights: Navigating Financial Challenges ... - Yahoo Finance

Oct 09, 2024
pulisher
Oct 09, 2024

Trevi Therapeutics Inc (TRVI) Q2 2024 Earnings Call Highlights: - GuruFocus.com

Oct 09, 2024
pulisher
Oct 08, 2024

Oppenheimer maintains Outperform on Trevi Therapeutics on Haduvio potential By Investing.com - Investing.com Canada

Oct 08, 2024
pulisher
Oct 07, 2024

Trevi Therapeutics' (TRVI) Buy Rating Reaffirmed at B. Riley - MarketBeat

Oct 07, 2024
pulisher
Oct 04, 2024

Trevi Therapeutics reports progress in clinical trials - Investing.com

Oct 04, 2024
pulisher
Oct 04, 2024

Trevi Therapeutics (NASDAQ:TRVI) Given "Buy" Rating at Needham & Company LLC - MarketBeat

Oct 04, 2024
pulisher
Oct 04, 2024

Trevi updates on clinical progress for chronic cough treatment - The Pharma Letter

Oct 04, 2024
pulisher
Oct 04, 2024

Trevi Therapeutics reports progress in clinical trials By Investing.com - Investing.com UK

Oct 04, 2024
pulisher
Oct 04, 2024

Trevi Therapeutics, Inc. Announces Updates on Its Clinical Development Programs - Marketscreener.com

Oct 04, 2024
pulisher
Oct 04, 2024

Trevi Therapeutics shares keep buy rating, positive trials By Investing.com - Investing.com UK

Oct 04, 2024
pulisher
Oct 04, 2024

Trevi Therapeutics hits 50% enrollment in IPF cough study By Investing.com - Investing.com South Africa

Oct 04, 2024
pulisher
Oct 03, 2024

Trevi Therapeutics hits 50% enrollment in IPF cough study - Investing.com India

Oct 03, 2024

Trevi Therapeutics Inc (TRVI) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Trevi Therapeutics Inc (TRVI) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
GOOD JENNIFER L
President & CEO
Sep 09 '24
Option Exercise
1.43
1,840
2,631
215,153
GOOD JENNIFER L
President & CEO
Sep 06 '24
Sale
3.03
4,219
12,784
213,313
GOOD JENNIFER L
President & CEO
Sep 09 '24
Sale
3.04
1,840
5,587
213,313
GOOD JENNIFER L
President & CEO
Sep 05 '24
Option Exercise
1.43
40,277
57,596
253,590
GOOD JENNIFER L
President & CEO
Sep 04 '24
Option Exercise
1.43
10,981
15,703
224,294
GOOD JENNIFER L
President & CEO
Sep 03 '24
Option Exercise
1.43
3,863
5,524
217,176
GOOD JENNIFER L
President & CEO
Sep 05 '24
Sale
3.11
40,277
125,310
213,313
GOOD JENNIFER L
President & CEO
Sep 04 '24
Sale
3.02
10,981
33,205
213,313
GOOD JENNIFER L
President & CEO
Sep 03 '24
Sale
3.02
3,863
11,677
213,313
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.56%
$367.36
price up icon 0.77%
$194.56
price up icon 0.07%
$108.23
price up icon 5.98%
大文字化:     |  ボリューム (24 時間):